SCHEMBL23488257

SCHEMBL23488257

Cc1ccc(OCc2ccccc2)cc1C(=O)OC[C@H]1O[C@@H](OCCS(C)(C)C)[C@H](O)[C@@H](O)[C@@H]1O

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.40
XDH P47989 1/20 0.39
MEN1 O00255 1/20 0.38
HSP90AA1 P07900 1/20 0.38
KMT2A Q03164 1/20 0.38
TYMP P19971 1/20 0.37
SLC5A2 P31639 3/20 0.37
NMT1 P30419 3/20 0.37
NMT2 O60551 1/20 0.37
SLC5A1 P13866 2/20 0.37
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PTPN2 P17706 1/20 0.36
PTPN1 P18031 1/20 0.36
CYP19A1 P11511 1/20 0.35
PRKCA P17252 1/20 0.35
SLC6A2 P23975 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23488256 0.89 MAOB (0.41) MAOBXDHMEN1HSP90AA1KMT2A
SCHEMBL23488267 0.87 MAOB (0.47) MAOBXDHTYMPTDP1
SCHEMBL23488472 0.87 MAOB (0.43) MAOBMEN1HSP90AA1KMT2ATYMP
SCHEMBL23488593 0.83 MAOB (0.44) MAOBMEN1HSP90AA1KMT2ANMT1
SCHEMBL23488152 0.83 MAOB (0.44) MAOBMEN1HSP90AA1KMT2ANMT1
SCHEMBL23488137 0.82 XDH (0.41) MAOBXDHMEN1KMT2ATYMP
SCHEMBL23488550 0.79 MAOB (0.43) MAOBXDHMEN1HSP90AA1KMT2A
SCHEMBL23488464 0.79 MAOB (0.43) MAOBXDHMEN1HSP90AA1KMT2A
SCHEMBL23488393 0.79 MAOB (0.39) MAOBXDHMEN1HSP90AA1KMT2A
SCHEMBL23488592 0.77 MAOB (0.44) MAOBMEN1HSP90AA1KMT2ANMT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN SANOFI (FR) 2021-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN GPR119, SLC2A8, SLC2A4 MAOB 4123/4885XDH 3028/4885MEN1 1749/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.